Following an invitation from Greek authorities, ECDC Director Marc Sprenger and experts from the ECDC Programmes for Sexually Transmitted Infections including HIV and blood-borne infections and Antimicrobial Resistance and Healthcare-associated Infections will visit Greece on 29 and 30 November 2012.
The study design and analysis controlled for influence of potentially confounding trends, such as improvement of day-care carriage and decreasing prevalence of smoking during the study period.
The sixth European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) opened today at the Edinburgh International Conference Centre (EICC).
The study compares the incidence and serotype distribution of invasive pneumococcal disease (IPD) for pneumococcal meningitis and non-meningitis IPD in children from 2007 to 2010 with reference to the pre-vaccination period from 1997 to 2001 in Germany.
The International AIDS Conference gathered those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. The AIDS 2012 programme presented new scientific knowledge and offered opportunities for dialogue on the major issues facing the global response to HIV.
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
The annual meeting of the healthcare-associated infections surveillance network (HAI-Net) and of the HAI-Net coordination group took place in Stockholm on 19-21 June 2012.
With more than 32 000 cases, gonorrhoea was the second most commonly reported sexually transmitted infection (STI) in Europe in 2010. As data from the ECDC report Gonococcal antimicrobial susceptibility surveillance in Europe 2010 illustrates, gonococci have become more resistant to common agents for treatment and show reduced susceptibility to newer antibiotics. “This indicates the risk that gonorrhoea may become an untreatable disease in the near future”, stresses ECDC Director Marc Sprenger.